Financial News
Fate Therapeutics (NQ: FATE )
3.840
+0.070
(+1.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Fate Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image-jobs.jpg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_600.png?width=1200&height=800&fit=crop)
What 6 Analyst Ratings Have To Say About Fate Therapeutics
January 05, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image_7.jpg?width=1200&height=800&fit=crop)
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
January 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image47.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/shutterstock_1940850556.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/04/image-alibaba.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/28/shutterstock_620657588.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_9591.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30794.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image17.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image45.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e87d7bb7-744e-43b6-8674-843e633747cf/small/logo-jpg.jpg)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
![](https://public.newsdirect.com/921481264/9k3wzirG.jpg)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
Fate Therapeutics to Present at Upcoming Investor Conferences
November 04, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5783.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/25/screenshot_2022-10-25_at_6.02.47_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.